Pricing Log in Create free account

Entera Bio Ltd. (ENTX) vs Rezolute, Inc. (RZLT)

Entera Bio Ltd. and Rezolute, Inc. are both Biotechnology companies. Entera Bio Ltd. and Rezolute, Inc. are of similar size ($471.1M and $462.4M). Across the 8 metrics below, Rezolute, Inc. leads on 6 and Entera Bio Ltd. on 2.

Valuation

Metric ENTX RZLT Biotechnology median
P/E n/m n/m 8.56
P/S 599.53 n/m 10.17
P/B 18.40 5.04 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 534.34 n/m 9.64
Earnings yield (13.21%) (15.57%) (29.41%)
Free cash flow yield (8.22%) (12.90%) (23.50%)

Profitability

Metric ENTX RZLT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.92%) (59.04%) (56.66%)
Return on assets (87.02%) (53.82%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTX RZLT Biotechnology median
Revenue growth (TTM) 66.42% — 5.64%
EPS growth (last fiscal year) 0.00% 23.47% 30.08%
Revenue growth, 5-year CAGR (29.19%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 9.68 4.72
Net debt to EBITDA 1.29 1.26 0.96

Dividend

Metric ENTX RZLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ENTX RZLT Biotechnology median
Market cap 462.40m 471.07m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack